Global Amphotericin B Market
Taille du marché en milliards USD
TCAC :
% 
USD
0.22 Billion
USD
0.30 Billion
2022
2030
 Période de prévision |
2023 –2030 |
 Taille du marché (année de référence) |
USD 0.22 Billion |
 Taille du marché (année de prévision) |
USD 0.30 Billion |
 TCAC |
% |
| Principaux acteurs du marché |
|
Global Amphotericin B Market, By Product Type (Static Drops, Atomization Inhalation, Local Lesion Injection, Other), Application (Vaginitis, Candida Infection, Leishmaniasis, Kala-Azar, Cryptococcal Infection, Aspergillus Infection, Other), Route of Administration (Intravenous, Parenteral, Oral, Other), Drug Class (Antifungals, Systemic, Other), End-Users (Clinic, Hospital, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) – Industry Trends and Forecast to 2030.
Amphotericin B Market Analysis and Size
Rise in the prevalence of fungal infections, emerging markets, rise in healthcare expenditure and growing government funds and initiatives for spreading awareness are the factors that will expand the global amphotericin B market. Rising R&D activities and clinical trials will provide beneficial opportunities for the global amphotericin B market in the forecast period of 2023-2030. Rise in the population that possess antifungal drug resistance and side effects of Amphotericin B such as blue lips, seizures, abdominal pain, numbness, fever, and other common effects are the factors that will hamper the market growth and will further challenge the global amphotericin B market in the forecast period.
Data Bridge Market Research analyzes that the global amphotericin b market which was USD 0.22 billion in 2022, would rocket up to USD 0.30 billion by 2030, and is expected to undergo a CAGR of 4.6% during the forecast period 2023 to 2030. This indicates the market value. “static drops” dominates the product segment of the global amphotericin b market owing to the increasing number of fungal diseases. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Amphotericin B Market Scope and Segmentation
|
Report Metric |
Details |
|
Forecast Period |
2023 to 2030 |
|
Base Year |
2022 |
|
Historic Year |
2021 (Customizable to 2015-2020) |
|
Quantitative Units |
Revenue in USD Million, Volumes in Units, Pricing in USD |
|
Segments Covered |
By Product Type (Static Drops, Atomization Inhalation, Local Lesion Injection, Other), Application (Vaginitis, Candida Infection, Leishmaniasis, Kala-Azar, Cryptococcal Infection, Aspergillus Infection, Other), Route of Administration (Intravenous, Parenteral, Oral, Other), Drug Class (Antifungals, Systemic, Other), End-Users (Clinic, Hospital, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) |
|
Countries Covered |
U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Saudi Arabia, U.A.E, South Africa, Egypt, Israel, rest of Middle East and Africa, Brazil, Argentina, and rest of South America |
|
Market Players Covered |
Bristol-Myers Squibb Company (US), MATINAS BIOPHARMA HOLDINGS, INC. (US), Nano-X Imaging LTD. (Israel), Nanomerics (UK), DNDi (Geneva), Abzena Ltd (UK), Bharat Serums and Vaccines Limited (BSV) (India), Astellas Pharma Inc.(Japan), Leadiant Biosciences (Italy), Inc., Lilly (US), InterMune (US), Jina Pharmaceuticals (US), SteriMax (India), and XGen Pharmaceuticals DJB, Inc. (US) among other |
|
Market Opportunities |
|
Market Definition
Amphotericin B is a polyene antifungal antibiotic which is produced by Streptomyces nodosus. It is used for the treatment of fungal infections in neutropenic patients, cryptococcal meningitis in HIV infection, fungal infections, and leishmaniasis. It acts by stopping the growth of fungi as it binds to ergosterol (an important component of fungal membrane). It further causes depolarization of the membrane and altering cell membrane permeability which leads to leakage of important intracellular components, cell rupture, and results in cell death. It is given by injection into a vein.
Amphotericin B Market Dynamics
Drivers
- Increase in cases of hospital acquired infection
Hospital-acquired infections (HAIs) can indeed contribute to an increase in the demand for medications such as Amphotericin B, which is an antifungal medication. HAIs are infections that patients acquire during their stay in a healthcare facility, including hospitals, clinics, and long-term care facilities. These infections can be caused by bacteria, viruses, fungi, or other pathogens, and they pose a significant challenge to patient care and overall healthcare systems.
- Increase in demand for effective antifungal drugs
Fungal infections have been on the rise globally, affecting various populations, including immunocompromised individuals, patients with chronic diseases, and those undergoing invasive medical procedures. Factors such as the aging population, increased use of immunosuppressive therapies, and the spread of drug-resistant fungal strains contribute to the growing incidence of fungal infections.
Opportunities
Growing unhygienic practices
Unhygienic practices and the presence of hospital-acquired infections are significant concerns for patient safety and public health. These practices can lead to increased rates of infections and pose serious risks to patients.
Restraints/Challenges
High investment requirements
However, obstacles such as high investment requirements, high treatment costs, and expensive capital expenditure on equipment are expected to stymie market expansion, as are technical challenges with sample collection and a lack of suitable reimbursement.
This global amphotericin b market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, the impact of domestic and localized market players, analyzes opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, and technological innovations in the market. To gain more info on the surgical microscopes market contact Data Bridge Market Research for an Analyst Brief, our team will help you make an informed market decision to achieve market growth.
Recent Developments
- In 2021, SP Accure Labs announced launching of amphotericin B emulsion. This drug is used in treatment of mucormycosis
- In 2021, Celon Laboratories announced launching of amphotericin B emulsion. This drug can be used in treatment of mucormycosis commonly known as black fungus
- In 2021, TLC a drug maker company announced the launch of liposomal amphotericin B in India. The product is named AmphoTLC and can be effective in the treatment of mucormycosis
Global Amphotericin B Market Scope
The global amphotericin b market is segmented on the basis of product type, application, route of administration, drug class, end-users, and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product Type
- STATIC DROPS,
- ATOMIZATION INHALATION,
- LOCAL LESION INJECTION,
- OTHER
Application
- VAGINITIS
- CANDIDA INFECTION
- LEISHMANIASIS
- KALA-AZAR
- CRYPTOCOCCAL INFECTION
- ASPERGILLUS INFECTION
- OTHER
Route Of Administration
- INTRAVENOUS
- PARENTERAL
- ORAL
- OTHERS
Drug Class
- ANTIFUNGALS
- SYSTEMIC
- OTHER
End User
- CLINIC
- HOSPITAL
- OTHERS
Distribution Channel
- HOSPITAL PHARMACY
- RETAIL PHARMACY
- ONLINE PHARMACY
Global Amphotericin B Market Regional Analysis/Insights
The global amphotericin b market is analyzed and market size insights and trends are provided by country, product type, application, route of administration, drug class, end-users, and distribution channel as referenced above.
The countries covered in the global amphotericin b market report are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, rest of Middle East and Africa, Brazil, Argentina, and rest of South America.
North America dominates the global amphotericin b market because of the increasing healthcare initiatives, the strong presence of major players in the market, increasing cases of chronic fungal conditions and rising number of research activities in this region.
Asia-Pacific is expected to witness significant growth during the forecast period of 2023 to 2030 due to the increase in government initiatives to promote awareness, growing research activities in the region, availability of massive untapped markets, large population pool, and the growing demand for quality healthcare in the region.
The country section of the report also provides individual market-impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points like downstream and upstream value chain analysis, technical trends, Porter's five forces analysis, and case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs, and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The global amphotericin b market also provides you with detailed market analysis for every country's growth in healthcare expenditure for capital equipment, installed base of different kinds of products for the global rare biomarkers market, the impact of technology using lifeline curves and changes in healthcare regulatory scenarios and their impact on the surgical microscopes market. The data is available for the historic period 2010-2020.
Competitive Landscape and Global Amphotericin B Market Share Analysis
The global amphotericin b market competitive landscape provides details of competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points provided are only related to the companies' focus related to the market.
Some of the major players operating in the global amphotericin b market are:
- Bristol-Myers Squibb Company (US)
- MATINAS BIOPHARMA HOLDINGS, INC. (US)
- Nano-X Imaging LTD. (Israel)
- Nanomerics (UK)
- DNDi (Geneva)
- Abzena Ltd (UK)
- Bharat Serums and Vaccines Limited (BSV) (India)
- Astellas Pharma Inc.(Japan)
- Leadiant Biosciences (Italy), Inc.
- Lilly (US), InterMune (US)
- Jina Pharmaceuticals (US)
- SteriMax (India)
- XGen Pharmaceuticals DJB, Inc. (US)
SKU-
Accédez en ligne au rapport sur le premier cloud mondial de veille économique
- Tableau de bord d'analyse de données interactif
- Tableau de bord d'analyse d'entreprise pour les opportunités à fort potentiel de croissance
- Accès d'analyste de recherche pour la personnalisation et les requêtes
- Analyse de la concurrence avec tableau de bord interactif
- Dernières actualités, mises à jour et analyse des tendances
- Exploitez la puissance de l'analyse comparative pour un suivi complet de la concurrence
Méthodologie de recherche
La collecte de données et l'analyse de l'année de base sont effectuées à l'aide de modules de collecte de données avec des échantillons de grande taille. L'étape consiste à obtenir des informations sur le marché ou des données connexes via diverses sources et stratégies. Elle comprend l'examen et la planification à l'avance de toutes les données acquises dans le passé. Elle englobe également l'examen des incohérences d'informations observées dans différentes sources d'informations. Les données de marché sont analysées et estimées à l'aide de modèles statistiques et cohérents de marché. De plus, l'analyse des parts de marché et l'analyse des tendances clés sont les principaux facteurs de succès du rapport de marché. Pour en savoir plus, veuillez demander un appel d'analyste ou déposer votre demande.
La méthodologie de recherche clé utilisée par l'équipe de recherche DBMR est la triangulation des données qui implique l'exploration de données, l'analyse de l'impact des variables de données sur le marché et la validation primaire (expert du secteur). Les modèles de données incluent la grille de positionnement des fournisseurs, l'analyse de la chronologie du marché, l'aperçu et le guide du marché, la grille de positionnement des entreprises, l'analyse des brevets, l'analyse des prix, l'analyse des parts de marché des entreprises, les normes de mesure, l'analyse globale par rapport à l'analyse régionale et des parts des fournisseurs. Pour en savoir plus sur la méthodologie de recherche, envoyez une demande pour parler à nos experts du secteur.
Personnalisation disponible
Data Bridge Market Research est un leader de la recherche formative avancée. Nous sommes fiers de fournir à nos clients existants et nouveaux des données et des analyses qui correspondent à leurs objectifs. Le rapport peut être personnalisé pour inclure une analyse des tendances des prix des marques cibles, une compréhension du marché pour d'autres pays (demandez la liste des pays), des données sur les résultats des essais cliniques, une revue de la littérature, une analyse du marché des produits remis à neuf et de la base de produits. L'analyse du marché des concurrents cibles peut être analysée à partir d'une analyse basée sur la technologie jusqu'à des stratégies de portefeuille de marché. Nous pouvons ajouter autant de concurrents que vous le souhaitez, dans le format et le style de données que vous recherchez. Notre équipe d'analystes peut également vous fournir des données sous forme de fichiers Excel bruts, de tableaux croisés dynamiques (Fact book) ou peut vous aider à créer des présentations à partir des ensembles de données disponibles dans le rapport.
